March 4 (Reuters) - Genetic Technologies Ltd (GTG) :
- GENETIC TECHNOLOGIES SIGNS MULTI-YEAR US DISTRIBUTION AGREEMENT FOR COVID RISK TEST
- GENETIC TECHNOLOGIES LTD - CO SIGNS CO-EXCLUSIVE PRODUCTION AND DISTRIBUTION RIGHTS AND LICENSE AGREEMENT WITH INFINITY BIOLOGIX LLC
- GENETIC TECHNOLOGIES LTD - IBX IS REQUIRED TO MAKE MINIMUM PAYMENTS TO CO TOTALING US$2.9 MILLION OVER TERM TO MAINTAIN EXCLUSIVITY
- GENETIC TECHNOLOGIES LTD - UNDERLYING ROYALTY STRUCTURE IS ON A PER UNIT BASIS OF US$10
- GENETIC TECHNOLOGIES LTD - IBX WILL DEFINE AND DECIDE SALES AND END-TO-CONSUMER PRICING STRUCTURE FOR COVID-19 RISK TEST
- GENETIC TECHNOLOGIES LTD - GTG TEAM IS IN FINAL STAGES TO SUBMIT COVID-19 RISK TEST FOR CLEARANCE FROM CLINICAL LABORATORY IMPROVEMENT AMENDMENTS
- Forums
- ASX - By Stock
- GTG
- News: GTG Genetic Technologies Signs Multi-Year US Distribution Agreement For COVID Risk Test
News: GTG Genetic Technologies Signs Multi-Year US Distribution Agreement For COVID Risk Test
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
-0.010(8.33%) |
Mkt cap ! $14.54M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 11.0¢ | $3.139K | 26.86K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 46 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 33251 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 46 | 0.115 |
2 | 37930 | 0.110 |
3 | 180000 | 0.105 |
14 | 250868 | 0.100 |
1 | 49000 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 33251 | 1 |
0.125 | 48254 | 4 |
0.130 | 66975 | 7 |
0.145 | 24000 | 1 |
0.155 | 30000 | 1 |
Last trade - 15.10pm 24/05/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |